Members |
targetComponentId |
Cardiomyopathy NOS |
Cardiomyopathy |
Cardiomyopathy due to drugs and other external agents |
Cardiomyopathy caused by drug |
Cardioplegia perfusion solution |
Cardioplegic solution agent (substance) |
Cardioplegia solution |
Cardioplegic solution agent (substance) |
Cardiovascular angiography NOS |
Angiocardiography |
Cardiovascular angiography NOS |
Angiocardiography |
Cardiovascular procedures NOS |
Procedure on cardiovascular system (procedure) |
Cardiovascular procedures NOS |
Procedure on cardiovascular system (procedure) |
Cardiovascular procedures NOS |
Procedure on cardiovascular system (procedure) |
cirrhose cardiotuberculeuse |
Cirrhosis of liver |
Care of Hickman catheter |
Care of central venous catheter (regime/therapy) |
soins de localisations corporelles |
Care regime |
Care of venous dissection |
Procedure on cardiovascular system (procedure) |
plan de soins |
Care plan (record artifact) |
Care plan |
Care plan (record artifact) |
Care plan |
Care plan (record artifact) |
Career guidance NOS |
Careers/vocational officers |
Career guidance NOS |
Careers/vocational officers |
soignant capable de faire face à une situation |
Caregiver able to cope (situation) |
l'aide familiale ne peut plus assumer |
Caregiver unable to cope (situation) |
le soignant est incapable de faire face à une situation |
Caregiver unable to cope (situation) |
Cares for mentally handicapped dependent |
Caregiver of dependent with intellectual disability |
Caretaker NOS |
Building caretaker |
Caretaker NOS |
Building caretaker |
Carglumic acid 200mg dispersible tablet |
Product containing precisely carglumic acid 200 milligram/1 each tablet for conventional release oral suspension (clinical drug) |
Carglutamic acid 200mg dispersible tablet |
Product containing precisely carglumic acid 200 milligram/1 each tablet for conventional release oral suspension (clinical drug) |
Caring environment |
Caring environment (finding) |
Carlavirus group |
Genus Carlavirus (organism) |
Carmellose sodium 0.5% eye drops |
Product containing precisely carmellose sodium 5 milligram/1 milliliter conventional release eye drops (clinical drug) |
Carmellose sodium 1% conventional release eye drops |
Product containing precisely carmellose sodium 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
Carmellose sodium 1% single-use eye drops |
Product containing precisely carmellose sodium 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
Carmustine 7.7mg wafer |
Product containing precisely carmustine 7.7 milligram/1 each prolonged-release intralesional implant (clinical drug) |
Carnobacterium piscicola |
Carnobacterium maltaromaticum (organism) |
Carotenosis cutis |
Carotene pigmentation of skin |
Carotid art.angiog-general NOS |
Angiography of carotid artery |
Carotid artery angiography - general NOS |
Angiography of carotid artery |
Carpal bones X-ray |
Plain X-ray of carpus (procedure) |
Carpal tunnel X-ray |
Plain X-ray of wrist, carpal tunnel view |
Carpenter Waziri syndrome |
X-linked intellectual disability hypotonic face syndrome |
Carvedilol 10mg controlled release capsule |
Product containing only carvedilol in oral dose form (medicinal product form) |
Carvedilol 10mg prolonged-release oral capsule |
Product containing only carvedilol in oral dose form (medicinal product form) |
Carvedilol 20mg controlled release capsule |
Product containing only carvedilol in oral dose form (medicinal product form) |
Carvedilol 20mg prolonged-release oral capsule |
Product containing only carvedilol in oral dose form (medicinal product form) |
Carvedilol 40mg controlled release capsule |
Product containing only carvedilol in oral dose form (medicinal product form) |
Carvedilol 40mg prolonged-release oral capsule |
Product containing only carvedilol in oral dose form (medicinal product form) |
Carvedilol 80mg controlled release capsule |
Product containing only carvedilol in oral dose form (medicinal product form) |
Carvedilol 80mg prolonged-release oral capsule |
Product containing only carvedilol in oral dose form (medicinal product form) |
Carya illinoensis |
Carya illinoinensis (organism) |
Carya illinoensis diagnostic allergen extract |
Carya illinoinensis diagnostic allergen extract (product) |
Carya illinoensis specific immunoglobulin E antibody measurement |
Carya illinoinensis specific immunoglobulin E antibody measurement (procedure) |
Cash handling clerk NOS |
Cash handling clerk |
Cash handling clerk NOS |
Cash handling clerk |
Casmerodius albus |
Ardea alba (organism) |
Casting or strapping procedure |
Stabilization |
Casualty,not due to war, of accident NOS |
Accidental event (event) |
Cat allergy vaccine |
Cat allergy vaccine (product) |
Cataract |
Abnormally opaque structure (morphologic abnormality) |
Cataract NOS |
Cataract |
Cataract NOS |
Cataract |
pneumonie catarrhale |
Pneumonia |
Catechin 15% topical ointment |
Catechin only product |
Catering manager NOS |
Catering manager |
Catering manager NOS |
Catering manager |
Catering source NOS |
Catering source |
Catering source NOS |
Catering source |
Catering supervisor NOS |
Catering supervisor |
Catering supervisor NOS |
Catering supervisor |
Catheter patency solutions |
Pharmaceutical fluid or solution agent (substance) |
Catheterisation of vessel NOS |
Insertion of vascular catheter (procedure) |
Catheterization of vessel NOS |
Insertion of vascular catheter (procedure) |
Cation |
Electrolyte cation (substance) |
Cauda equina injury without bone injury |
Cauda equina injury without spinal bone injury (disorder) |
Cauda equina injury without bony injury |
Cauda equina injury without spinal bone injury (disorder) |
Cauliflower |
Cauliflower (substance) |
Cauliflower - dietary |
Cauliflower (substance) |
Caustic burn of skin |
Chemical burn of skin |
Caustic esophageal injury |
Esophageal injury caused by alkali (disorder) |
Caustic injected into tumor |
Injection of caustic into neoplasm |
Caustic injected into tumour |
Injection of caustic into neoplasm |
Cauterisation NOS |
A destruction of tissue by burning or searing with a thermal instrument, an electric current, or a caustic substance. |
Cauterization NOS |
A destruction of tissue by burning or searing with a thermal instrument, an electric current, or a caustic substance. |
cautérisation de lésion de périnée chez la femme |
Cauterisation of lesion of perineum |
Cauterization of lesion of organ NOC |
A destruction of tissue by burning or searing with a thermal instrument, an electric current, or a caustic substance. |
Cauterization of organ NOC |
A destruction of tissue by burning or searing with a thermal instrument, an electric current, or a caustic substance. |
Cauterization of organ NOC NOS |
A destruction of tissue by burning or searing with a thermal instrument, an electric current, or a caustic substance. |
Cauterization of organ NOC OS |
A destruction of tissue by burning or searing with a thermal instrument, an electric current, or a caustic substance. |
CdE genotype |
CdE haplotype (finding) |
Cefaclor 125mg/5mL s/f suspension |
Product containing precisely cefaclor anhydrous (as cefaclor) 25 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Cefaclor 187mg/5mL suspension |
Product containing precisely cefaclor anhydrous (as cefaclor) 37.4 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Cefaclor 250mg chewable tablet |
Product containing precisely cefaclor 250 milligram/1 each conventional release chewable tablet (clinical drug) |
Cefaclor 250mg/5mL s/f suspension |
Cefaclor 50 mg/mL oral suspension |
Cefaclor 375mg m/r tablet |
Product containing precisely cefaclor 375 milligram/1 each prolonged-release oral tablet (clinical drug) |
Cefaclor 375mg tablet |
Product containing precisely cefaclor 375 milligram/1 each prolonged-release oral tablet (clinical drug) |
Cefaclor 375mg/5mL suspension |
Cefaclor anhydrous (as cefaclor) 75 mg/mL oral suspension |
Cefaclor 500mg m/r tablet |
Product containing only cefaclor in oral dose form (medicinal product form) |
Cefaclor 500mg prolonged-release oral tablet |
Product containing only cefaclor in oral dose form (medicinal product form) |
Cefaclor anhydrous 250mg capsule |
Product containing precisely cefaclor 250 milligram/1 each conventional release oral capsule (clinical drug) |
Cefaclor extract |
Product containing cefaclor (medicinal product) |
Cefaclor monohydrate 125mg/5 mL powder for oral suspension |
Product containing precisely cefaclor anhydrous (as cefaclor) 25 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Cefaclor monohydrate 187mg/5 mL powder for oral suspension |
Product containing precisely cefaclor anhydrous (as cefaclor) 37.4 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Cefaclor monohydrate 187mg/5mL suspension |
Product containing precisely cefaclor anhydrous (as cefaclor) 37.4 milligram/1 milliliter conventional release oral suspension (clinical drug) |